Evidence map›Paper›PMID 42004573›Full record

ArticleAmerican journal of health economics2026

E-CIGARETTE FLAVOR RESTRICTIONS' EFFECTS ON TOBACCO PRODUCT SALES.

Abigail S Friedman, Alex C Liber, Alyssa Crippen, Michael F Pesko

Abstract read
In one paragraph

Article in American journal of health economics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Responses to Real-World and Hypothetical E-Cigarette Flavor Bans Among US Young Adults Who Use Flavored E-Cigarettes.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Abigail S FriedmanDepartment of Health Policy and Management, Yale School of Public Health.
Alex C LiberLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University School of Medicine.
Alyssa CrippenDepartment of Health Policy and Management, Yale School of Public Health.
Michael F PeskoDepartment of Economics, University of Missouri.

Funding

Research Project 3: Modeling the Impact of Tobacco Control Policies on Polytobacco Use and Associated Health DisparitiesU54CA229974 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Rafael Meza · 2018 to 2026
$39.2M
The Impacts of Vaping Regulations on Perceptions, Access, Prices, and Tobacco UseR01DA045016 · NIDA · UNIVERSITY OF MISSOURI-COLUMBIA · PI Michael Pesko · 2018 to 2026
$4.2M
NCI NIH HHS U54 CA229974NIDA NIH HHS R01 DA045016
6 · The paper itself

Abstract

More than 385 US localities and 7 states have implemented restrictions on sales of flavored electronic nicotine delivery systems (ENDS), yet these policies' effects remain unclear. Utilizing comprehensive data on tobacco product flavor policies linked to retail sales data from January 2018 through March 2023, we estimate the effects of these restrictions. Our findings reveal that ENDS flavor restrictions yield substantial decreases in total ENDS sales, primarily owing to significant declines in flavored ENDS sales alongside nonsignificant increases in unflavored ENDS sales. Further analyses find that ENDS flavor restrictions increase sales of combustible cigarettes, a more harmful product: 11 to 15 additional cigarettes are purchased for every 1 less 0.7 mL ENDS pod sold because of these policies. This uptick in cigarette sales stems primarily from non-menthol cigarettes and includes brands disproportionately used by underage youth. These findings suggest that the public health benefits from reducing ENDS sales via flavor restrictions may be offset by the public health costs of consequent increases in cigarette consumption.

Indexed as

health behaviorI12I18public health policytobacco

Identifiers

PMID42004573
PMCPMC13089908

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.